Search research articles
Contact Us
Filters
Showing results (161-170 of 211) with videos related to
Page
of 22
Sort By:
Scientific Data
|
March 5, 2026
WxC-Bench: A Novel Dataset for Weather and Climate Downstream Tasks
Rajat Shinde, Kumar Ankur, Christopher E Phillips, et al.
Molecular Psychiatry
|
July 27, 2022
Longitudinal trajectories of cortical development in 22q11.2 copy number variants and typically developing controls
Maria Jalbrzikowski, Amy Lin, Ariana Vajdi, et al.
Pharmacoeconomics
|
March 12, 2003
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C
Jens Rasenack, Stefan Zeuzem, S Victor Feinman, et al.
Annals of Internal Medicine
|
March 5, 2004
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose
Stephanos J Hadziyannis, Hoel Sette, Timothy R Morgan, et al.
The New England Journal of Medicine
|
September 27, 2002
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
Michael W Fried, Mitchell L Shiffman, K Rajender Reddy, et al.
Gastroenterology
|
July 20, 2010
A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin
Mark G Swain, Ming-Yang Lai, Mitchell L Shiffman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2013
Combined alloreactive CTL cellular therapy with prodrug activator gene therapy in a model of breast cancer metastatic to the brain
Michelle J Hickey, Colin C Malone, Kate L Erickson, et al.
Hepatology (Baltimore, Md.)
|
August 13, 2008
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirin
Michael W Fried, Donald M Jensen, Maribel Rodriguez-Torres, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
September 12, 2013
Depressive symptoms in Chinese-American subjects with cognitive impairment
Steven Z Chao, Brandy R Matthews, Jennifer S Yokoyama, et al.
Journal of Medicinal Chemistry
|
October 5, 2022
Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase Inhibitors
Rongjun He, Jifeng Wang, Zhi-Hong Yu, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 211) with videos related to
Sort By:
Page
of 22
Scientific Data
|
March 5, 2026
WxC-Bench: A Novel Dataset for Weather and Climate Downstream Tasks
Rajat Shinde, Kumar Ankur, Christopher E Phillips, et al.
Molecular Psychiatry
|
July 27, 2022
Longitudinal trajectories of cortical development in 22q11.2 copy number variants and typically developing controls
Maria Jalbrzikowski, Amy Lin, Ariana Vajdi, et al.
Pharmacoeconomics
|
March 12, 2003
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C
Jens Rasenack, Stefan Zeuzem, S Victor Feinman, et al.
Annals of Internal Medicine
|
March 5, 2004
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose
Stephanos J Hadziyannis, Hoel Sette, Timothy R Morgan, et al.
The New England Journal of Medicine
|
September 27, 2002
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
Michael W Fried, Mitchell L Shiffman, K Rajender Reddy, et al.
Gastroenterology
|
July 20, 2010
A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin
Mark G Swain, Ming-Yang Lai, Mitchell L Shiffman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2013
Combined alloreactive CTL cellular therapy with prodrug activator gene therapy in a model of breast cancer metastatic to the brain
Michelle J Hickey, Colin C Malone, Kate L Erickson, et al.
Hepatology (Baltimore, Md.)
|
August 13, 2008
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirin
Michael W Fried, Donald M Jensen, Maribel Rodriguez-Torres, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
September 12, 2013
Depressive symptoms in Chinese-American subjects with cognitive impairment
Steven Z Chao, Brandy R Matthews, Jennifer S Yokoyama, et al.
Journal of Medicinal Chemistry
|
October 5, 2022
Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase Inhibitors
Rongjun He, Jifeng Wang, Zhi-Hong Yu, et al.
Page
of 22